CORE to be Premier and Interactive Sponsor for ACDM22
Date: August 12, 2021
The Association for Clinical Data Management is delighted to announce that CORE from the Clinical Informatics Research Unit, Faculty of Medicine at the University of Southampton will be a Premier and Interactive Sponsor of ACDM22.
CORE covers a range of expert services which include the design, build and running of electronic forms used in clinical trials across the UK and overseas. Not only does CORE create the forms you need, it also offers randomisation, data management and provides you with those all-important study statistics. CORE has developed a fruitful partnership with FormsVision BV, which the unit first engaged with under a FP7 EU funding framework, and has successfully deployed ALEA EDC with the features of eCRF (electronic Case Report Form), randomisation and other benefits, that support clinical trials in both the commercial and non-commercial setting.
ACDM22 is the 2022 Annual Conference of the Association for Clinical Data Management and is being held in Edinburgh, Scotland, from the 13th-15th March 2022.
Explore More News

Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available
The ICH Working Groups and The ICH Training Associates have released two new training . . .
Read More

Recent update from the regulatory landscape in clinical data management
On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .
Read More

Regulatory Considerations DMEG Update – August 2026
Please read the following update from the Regulatory Considerations DMEG:
July and . . .
Read More

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan
We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .
Read More

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG
Health Canada (HC) continues to publish new guidelines to support their modernization of . . .
Read More

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance
Thank you to the Regulatory Considerations DMEG for sharing this update.
Health Canada . . .
Read More

Recent update from the regulatory landscape in clinical data management
Thank you to the Regulatory Considerations DMEG for sharing this update.
On July 15 the . . .
Read More

Regulatory Considerations DMEG Update – June 2026
Please read the following update from the Regulatory Considerations DMEG:
Regulators have . . .
Read More

FDA Announces New Initiative for Real-Time Clinical Trials
The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .
Read More

Get to know ACDM Board Member Jennifer Duff
We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .
Read More

Recent News in Regulatory Landscape
The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .
Read More

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda
Tamer Chowdhury, on behalf of ACDM Technology DMEG.
On April 28, FDA Commissioner Dr. . . .
Read More